JP2007505887A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007505887A5 JP2007505887A5 JP2006526719A JP2006526719A JP2007505887A5 JP 2007505887 A5 JP2007505887 A5 JP 2007505887A5 JP 2006526719 A JP2006526719 A JP 2006526719A JP 2006526719 A JP2006526719 A JP 2006526719A JP 2007505887 A5 JP2007505887 A5 JP 2007505887A5
- Authority
- JP
- Japan
- Prior art keywords
- pace4
- pharmaceutical composition
- inhibitor
- blocker
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 101001098833 Homo sapiens Proprotein convertase subtilisin/kexin type 6 Proteins 0.000 claims 11
- 102100038946 Proprotein convertase subtilisin/kexin type 6 Human genes 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 239000003112 inhibitor Substances 0.000 claims 3
- 108010003059 aggrecanase Proteins 0.000 claims 2
- 206010003246 arthritis Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229940125532 enzyme inhibitor Drugs 0.000 claims 2
- 239000002532 enzyme inhibitor Substances 0.000 claims 2
- 230000014509 gene expression Effects 0.000 claims 2
- 101150010353 Ascl1 gene Proteins 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
Claims (7)
- 関節炎治療のための医薬品の製造における、ＰＡＣＥ４阻害剤の使用。
- 薬学的に許容される担体と共に、ＰＡＣＥ４遮断剤を含む関節炎治療のための医薬組成物。
- ＰＡＣＥ４遮断剤がＰＡＣＥ４酵素阻害剤である、請求項２に記載の医薬組成物。
- ＰＡＣＥ４酵素阻害剤が、ＰＡＣＥ４に特異的であり且つＰＡＣＥ４を不活化させる能力を有する、１つ又はそれ以上のモノクローナル抗体である、請求項３に記載の医薬組成物。
- ＰＡＣＥ４遮断剤がＰＡＣＥ４遺伝子発現の阻害剤である、請求項２に記載の医薬組成物。
- ＰＡＣＥ４遺伝子発現の阻害剤が、ｈＡＳＨ−１及びＭＡＳＨ−１から成るグループから選択される１つ又は２つの化合物である、請求項５に記載の医薬組成物。
- 有効量のＰＡＣＥ４遮断剤を含む、アグレカナーゼ前駆体から機能的に活性なアグレカナーゼへの活性化を防止するための医薬。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50319603P | 2003-09-16 | 2003-09-16 | |
| PCT/IB2004/002948 WO2005025611A1 (en) | 2003-09-16 | 2004-09-12 | Inhibitors of pace4 for the treatment of arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007505887A JP2007505887A (ja) | 2007-03-15 |
| JP2007505887A5 true JP2007505887A5 (ja) | 2007-11-01 |
Family
ID=34312434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006526719A Withdrawn JP2007505887A (ja) | 2003-09-16 | 2004-09-12 | 関節炎治療のためのｐａｃｅ４阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050090466A1 (ja) |
| EP (1) | EP1663300A1 (ja) |
| JP (1) | JP2007505887A (ja) |
| BR (1) | BRPI0414423A (ja) |
| CA (1) | CA2539300A1 (ja) |
| MX (1) | MXPA06002916A (ja) |
| WO (1) | WO2005025611A1 (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010003231A1 (en) * | 2008-07-11 | 2010-01-14 | Socpra-Sciences Et Génie S.E.C. | Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
| WO2011144517A1 (en) * | 2010-05-12 | 2011-11-24 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Furin and biologically active derivatives thereof for use in the prevention or treatment of an inflammatory disease |
| CA2846287C (en) * | 2011-09-02 | 2021-06-22 | Socpra-Sciences Sante Et Humaines S.E.C. | Stable peptide-based pace4 inhibitors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993018159A2 (en) * | 1992-03-09 | 1993-09-16 | Chiron Corporation | Compositions and methods for pace 4 and 4.1 gene and polypeptides in cells |
| US6506559B1 (en) * | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| JP2003526367A (ja) * | 2000-03-16 | 2003-09-09 | ジェネティカ インコーポレイテッド | Ｒｎａ干渉の方法とｒｎａ干渉組成物 |
| JP2004533841A (ja) * | 2001-07-05 | 2004-11-11 | ワイス | アグレカナーゼ分子 |
| GB0217136D0 (en) * | 2002-07-24 | 2002-09-04 | Renovo Ltd | Wound healing & treatment of fibrosis |
| US20040086860A1 (en) * | 2002-10-04 | 2004-05-06 | Muhammad Sohail | Methods of producing RNAs of defined length and sequence |
| US20040077082A1 (en) * | 2002-10-18 | 2004-04-22 | Koehn Richard K. | RNA-based inhibitory oligonucleotides |
-
2004
- 2004-09-12 JP JP2006526719A patent/JP2007505887A/ja not_active Withdrawn
- 2004-09-12 BR BRPI0414423-6A patent/BRPI0414423A/pt not_active IP Right Cessation
- 2004-09-12 CA CA002539300A patent/CA2539300A1/en not_active Abandoned
- 2004-09-12 WO PCT/IB2004/002948 patent/WO2005025611A1/en active Application Filing
- 2004-09-12 MX MXPA06002916A patent/MXPA06002916A/es not_active Application Discontinuation
- 2004-09-12 EP EP04769343A patent/EP1663300A1/en not_active Withdrawn
- 2004-09-16 US US10/942,581 patent/US20050090466A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2401658C2 (ru) | Гетероциклические ингибиторы аспартилпротеазы | |
| JP2009510171A5 (ja) | ||
| JP2010532765A5 (ja) | ||
| JP2010285439A5 (ja) | ||
| JP2005518433A5 (ja) | ||
| RU2009107535A (ru) | Применение 3-(4-амино-1-оксо-1,3-дигидроизоиндол-2-ил)пиперидин-2,6-диона для лечения лимфом из клеток мантийной зоны | |
| WO2007081949A3 (en) | Small-volume oral transmucosal dosage forms | |
| EP3276004A3 (en) | Methods for treating chronic kidney disease | |
| WO2009017838A3 (en) | Combinations of jak-2 inhibitors and other agents | |
| JP2008543776A5 (ja) | ||
| IL173078A0 (en) | Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form | |
| JP2007523049A5 (ja) | ||
| DK1161248T3 (da) | Farmaceutisk sammensætning indeholdende en nitratkilde og et forsurende middel til behandling af åbne sår og forbrændinger | |
| WO2006084474A3 (en) | A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an hmg-coa reductase inhibitor | |
| WO2007103557A3 (en) | Coating capsules with active pharmaceutical ingredients | |
| EA200970081A1 (ru) | Соединения, обладающие потенциирующим действием в отношении активности этионамида, и их применения | |
| GEP20125691B (en) | Compounds and compositions as protein kinase inhibitors | |
| EP1283054A4 (en) | MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF | |
| JP2009545600A5 (ja) | ||
| WO2007112014A3 (en) | New therapeutic combinations for the treatment of depression | |
| TW200640487A (en) | Combination of XOLAIR with immunosuppressive agent | |
| MA26964A1 (fr) | Association d'agonistes de gaba et d'inhibiteurs de sorbitol-deshydrogenase. | |
| JP2009516719A5 (ja) | ||
| ATE525359T1 (de) | Modulatoren der aktivität des glucokortikoidrezeptors von ap-1 und/oder von nf- kb und anwendung davon | |
| EA200701681A1 (ru) | Пероральная лекарственная форма, содержащая росиглитазон |